Prototype Web Portal Shows Technology’s Potential to Protect and Streamline the Clinical Trials Process
UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain. The system creates an immutable audit trail that makes it easy to spot any tampering with results—such as making the treatment look more effective or diminishing side effects.
“Everyone is talking about how blockchain is going to revolutionize many of the data challenges in medicine, and here is one use that finally might make sense,” said Atul Butte, MD, PhD, who is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and director of the Bakar Computational Health Sciences Institute at UCSF. “We think it could someday be useful for pharma companies running clinical trials.”
The research was published February 22 in Nature Communications.
Blockchain technology utilizes an old computer science technique known as hashing, which creates a unique digital signature for each so-called block of data. The hashes accumulate sequentially, as new data is entered or changed, with each block depending on the last. The resulting “blockchain” creates an audit trail for regulators that is easy to decipher and validate, even without looking at the actual data.
Daniel Wong, a PhD candidate in Biological and Medical Informatics at UCSF, built the system to operate through a web portal, so that each time new data is entered on a given trial participant, the sender, receiver, timestamp, and file attachment containing the data, along with the hash of the previous block of data pertaining to that patient, is recorded onto a new block, with its own distinct signature.
Unlike the decentralized nature of most blockchain applications, this clinical trial prototype depends on having a regulator with centralized authority, such as the U.S. Food and Drug Administration, to operate the web portal, register all parties, and keep a ledger of the blockchain’s hashes.
Data, including adverse events, would be reported to the regulatory agency in real time, which may provide a boost to the safety and efficiency of clinical trials. While the prototype makes allowances for data entry or other errors to be corrected, new data can only be appended to the existing chain, without erasing what was there before.
“It makes it really obvious when someone’s changing something,” Wong said. “You can see who put their hands on it, who made it, who changed it, and who received it.”
Wong tested the system with a small subset of data from a real, previously run phase II trial included in ImmPort, a repository of open clinical trial data funded by the National Institutes of Allergy and Infectious Diseases (NIAID) that is managed by Butte’s lab and collaborators.
After entering the original data, he logged in as the trial sponsor and tried to erase adverse events that had been reported for two patients in their case report forms. Instead of deleting those reports, however, the system appended his changes to the original data, making it clear who had tried to corrupt the forms, when it was done, and what had been changed.
Wong also tried corrupting the data stored from an earlier point in the trial, when patients were assigned to different treatment arms—drug or placebo—to make it look as though they had been given a different medication plan. But the blockchain ledger pinpointed exactly what had changed and when.
A prototype system like this reduces risks, but does not completely protect data from tampering. Even within a system enabled with this type of blockchain technology, the authors pointed out, it is still possible that those seeing patients at the point of care could enter wrong or incorrect data at the outset.
But blockchain technology could enable trials to be conducted under challenging conditions, or open doors to data exchanges that are more secure, more efficient, and more transparent for both researchers and the general public.
“A system built upon our prototype could be developed to enable oversight of international clinical trials, for example,” Butte said. “And it could be expanded to provide more access to raw data for research scientists, the way we do with ImmPort, or deliver trial results to the public.”
The Latest on: Blockchain
via Google News
The Latest on: Blockchain
- Privacy 'poisoning' poses threat to companies using blockchain on April 17, 2019 at 3:01 pm
A new type of cyberattack that can render blockchain technology unusable may become a major headache for organizations that depend on it. Known as privacy "poisoning," the attack involves loading ... […]
- Coming soon: A token taxonomy to define the world of blockchain on April 17, 2019 at 10:46 am
The Enterprise Ethereum Alliance (EEA) is working with Microsoft and more than a dozen businesses, research organizations and industry consortiums to create a blockchain-neutral business-focused Token ... […]
- New U.S. venture capital fund launched with focus on blockchain; $50 million funding on April 17, 2019 at 8:14 am
NEW YORK (Reuters) - Proof of Capital, a U.S. venture capital fund, was launched on Wednesday with funding of $50 million, its founders said in a statement. The fund will invest in blockchain projects ... […]
- Proof of Capital is a new $50M blockchain fund that’s backed by HTC on April 17, 2019 at 8:03 am
It’s often said that the dramatic fall of crypto prices last year ushered in a new era for technology-focused startups in the blockchain space, and the same argument can be made for the venture ... […]
- Proof of Capital launches $50 million blockchain venture fund on April 17, 2019 at 8:02 am
Blockchain venture funds are multiplying. Today, Proof of Capital announced a $50 million VC fund to invest in blockchain technologies using the decentralized, transparent, and secure technology ... […]
- New $50 Million Venture Fund Eyes Global Blockchain Adoption on April 17, 2019 at 8:00 am
A group of investors has launched a new blockchain-focused venture capital fund worth $50 million, aiming to bring the technology to the masses. The fund, called Proof of Capital, has been founded by ... […]
- The London Stock Exchange is trialing blockchain for stocks on April 17, 2019 at 7:45 am
The London Stock Exchange (LSE) has allowed technology company 20|30 to sell shares worth around £3 million ($3.9 million) in tokenized form, according to the Telegraph. The transactions were settled ... […]
- Hollywood Does Blockchain—With Not-Disastrous Results on April 17, 2019 at 6:00 am
You may have heard that bitcoin—no, excuse me, blockchain—is boring these days. I disagree; the real drama comes after the crash. One recent true story: A 30-year-old crypto CEO, (apparently) dead of ... […]
- Blockchain Goes To Work At Walmart, IBM, Amazon, JPMorgan, Cargill and 45 Other Enterprises on April 17, 2019 at 5:46 am
n the Jersey side of the Hudson River just across from Manhattan’s Financial District, there is a glass-and-steel office tower designed in a severe International Style aesthetic. “DTCC” is emblazoned ... […]
- Accenture, Generali Streamline Employee Insurance Benefits With Blockchain Rollout on April 17, 2019 at 3:25 am
Professional services firm Accenture and Italian insurance group Generali have launched a blockchain solution that brings employee benefits into the digital age. The product is aimed to streamline ... […]
via Bing News